Negative Symptoms in Schizophrenia: A Review and Clinical Guide for Recognition, Assessment, and Treatment

by Correll CU, Schooler NR
Published 2020-02-01

Relationship between the timing of relapse and plasma drug levels following discontinuation of cariprazine treatment in patients with schizophrenia: indirect comparison with other...

by Correll CU, Jain R, Meyer JM, Periclou A, Carrothers T, Barabássy Á, Patel M, Earley W
Published 2019-08-01

Exploration of Treatment-Resistant Schizophrenia Subtypes Based on a Survey of 204 US Psychiatrists

by Correll CU, Brevig T, Brain C
Published 2019-12-01

Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review

by Solmi M, Murru A, Pacchiarotti I, Undurraga J, Veronese N, Fornaro M, Stubbs B, Monaco F, Vieta E, Seeman MV, Correll CU, Carvalho AF
Published 2017-06-01

Treatment of tardive dyskinesia with VMAT-2 inhibitors: a systematic review and meta-analysis of randomized controlled trials

by Solmi M, Pigato G, Kane JM, Correll CU
Published 2018-05-01

Initiating/maintaining long-acting injectable antipsychotics in schizophrenia/schizoaffective or bipolar disorder – expert consensus survey part 2

by Sajatovic M, Ross R, Legacy SN, Byerly M, Kane JM, DiBiasi F, Fitzgerald H, Correll CU
Published 2018-06-01

Identifying patients and clinical scenarios for use of long-acting injectable antipsychotics – expert consensus survey part 1

by Sajatovic M, Ross R, Legacy SN, Correll CU, Kane JM, DiBiasi F, Fitzgerald H, Byerly M
Published 2018-06-01

Clinical relevance of paliperidone palmitate 3-monthly in treating schizophrenia

by Mathews M, Gopal S, Nuamah I, Hargarter L, Savitz AJ, Kim E, Tan W, Soares B, Correll CU
Published 2019-05-01